Average Co-Inventor Count = 7.23
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Aktiengesellschaft (5 from 1,384 patents)
2. Bayer Schering Pharma Ag (5 from 192 patents)
3. Bayer Intellectual Property Gmbh (2 from 721 patents)
4. Novartis Ag (1 from 3,923 patents)
5. Schering Aktienegesellschaft (1 from 1 patent)
14 patents:
1. 8642611 - Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
2. 8198456 - Dihydropyridine derivatives as useful as protein kinase inhibitors
3. 8003655 - Substituted sulphoximines as TIE2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
4. 7906533 - Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
5. 7902229 - Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
6. 7572794 - Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
7. 7517894 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
8. 7479491 - Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors
9. 7459470 - N-oxide anthranylamide derivatives and their use as medicaments
10. 7429592 - Cyanoanthranilamide derivatives and the use thereof as medicaments
11. 7338958 - Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
12. 7202260 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
13. 7081468 - Ortho-substituted anthranilic acid amides and their use as medicaments
14. 7012081 - Anthranyl amides and their use as medicaments